LVMH is restructuring its beauty portfolio amid a luxury market slowdown, with reports of a potential sale of its 50% stake in Fenty Beauty and a $20 million investment in dermatologist-developed skincare brand Remedy through its affiliated private equity firm L Catterton. These moves, alongside a luxury stock rally tied to geopolitical developments, indicate how the conglomerate is navigating economic pressures and shifting consumer demand. For overseas buyers and distributors, the reshuffle signals potential changes in brand ownership, distribution strategies, and opportunities in clinically-focused skincare.
Fenty Beauty Stake Sale
MarcyPen Capital Partners, an investment firm backed by rapper Jay-Z, is reportedly pursuing LVMH's 50% stake in Fenty Beauty. The inclusive makeup brand, launched by singer Rihanna in partnership with Kendo Brands in 2017, generated approximately $450 million in net sales in 2024 and could be valued between $1–2 billion. MarcyPen manages about $1.1 billion in assets, including Merit Beauty and Rael, and previously invested in Rihanna's Savage X Fenty. LVMH is also reportedly exploring options for Make Up For Ever and Fresh.
Remedy Series A Funding
Dermatologist-developed skincare brand Remedy has raised $20 million in Series A funding led by L Catterton, the LVMH-affiliated private equity firm. The investment aims to deepen capabilities in formulation, testing, and consumer education, as well as expand clinical research and product pipeline. Remedy, founded by board-certified dermatologist Dr. Muneeb Shah, has seen significant growth across DTC, Amazon, TikTok Shop, and Target after its nationwide launch in December 2025. The brand focuses on clinically-tested, high-efficacy formulas for sensitive skin.
Luxury Market and Geopolitical Impact
Luxury stocks, including LVMH, spiked about 5% after a proposed US-Iran deal outlined reopening the Strait of Hormuz. The Middle East region accounts for about 6% of LVMH's group sales, and the Iran war had previously cut quarterly organic growth in half. LVMH lost approximately €100 billion in market value over the past 12 months amid a broad luxury demand slowdown. The stock rally underscores the sector's sensitivity to geopolitical stability and consumer confidence.
What Buyers Should Watch
For overseas importers and distributors, the potential sale of Fenty Beauty could lead to changes in brand management, distribution channels, and market positioning. The Remedy investment signals growing demand for clinically-backed, dermatologist-developed skincare, which may open opportunities for partnerships or sourcing in the dermocosmetic segment. LVMH's portfolio reshuffle also suggests possible shifts in brand availability and pricing strategies, particularly in the luxury beauty space. Monitoring these developments can help buyers anticipate supply chain adjustments and new product launches.
Source: Read the original report | Published: June 15, 2026